Catalyst Wire Dossier Catalyst Wire Dossier

Ditropan

oxybutynin
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Ditropan, covering 2011-05-19 to 2025-08-11. Get the full timeline:

Most recent: Clinical Trial Update: The Effect of Nighttime Mirabegron, Solifenacin, Tolterodine, or Oxybutynin on Nocturia, Sexual Function, Autonomic Function, and Lower Urinary Tract Blood Flow Perfusion in Women With Overactive Bladder Syndrome: Randomized Controlled Trial [Phase 3]

See pricing